VMGIX | WENRX | VMGIX / WENRX | |
Total Expense Ratio | 0.19 | 0.80 | 24% |
Annual Report Gross Expense Ratio | 0.19 | 0.81 | 23% |
Fund Existence | 19 years | 11 years | - |
Gain YTD | 12.372 | 13.118 | 94% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 3000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 32.4B | 649M | 4,992% |
Annual Yield % from dividends | 0.51 | 0.00 | - |
Returns for 1 year | 22.81 | 12.56 | 182% |
Returns for 3 years | 37.41 | 25.27 | 148% |
Returns for 5 years | 59.92 | -4.37 | -1,372% |
Returns for 10 years | 167.01 | 30.53 | 547% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
LFSC | 27.27 | 0.19 | +0.72% |
F/m Emerald Life Sciences Innovation ETF | |||
QTAP | 43.08 | N/A | N/A |
Innovator Growth-100 Acltd Ps ETF™ April | |||
OCIO | 36.28 | -0.04 | -0.12% |
ClearShares OCIO ETF | |||
GCOR | 41.22 | -0.07 | -0.17% |
Goldman Sachs Access US Aggregate Bd ETF | |||
AVLV | 70.60 | -0.23 | -0.32% |
Avantis US Large Cap Value ETF |